Catalyst Wire Dossier Catalyst Wire Dossier

Naltrexone implant (DLP-160)

Naltrexone · Delpor, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naltrexone implant (DLP-160), covering 2025-02-13 to 2025-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160) [Phase 1]

See pricing